Prosthetic mesh placement may leads to lower subgroup analysis:Incidence of parastomal hernia (laparoscopic… compared with standard treatment (low certainty).
Prosthetic mesh placement probably leads to lower subgroup analysis:Incidence of parastomal hernia (open surgery) ( compared with standard treatment (moderate certainty).
Prosthetic mesh placement probably leads to lower subgroup analysis:Incidence of parastomal hernia (sublay… compared with standard treatment (moderate certainty).
Prosthetic mesh placement showed no clear difference in subgroup analysis:Incidence of parastomal hernia (intraperitoneal… compared with standard treatment (moderate certainty).
Prosthetic mesh placement may leads to lower incidence of parastomal hernia (worst‐case scenario sensitivity… compared with standard treatment (low certainty).
Prosthetic mesh placement may leads to lower incidence of parastomal hernia (best‐case scenario sensitivity… compared with standard treatment (low certainty).
Prosthetic mesh placement showed no clear difference in reoperation rate ( compared with standard treatment (low certainty).
Prosthetic mesh placement showed no clear difference in operative time for index procedure ( compared with standard treatment (low certainty).
Prosthetic mesh placement showed no clear difference in postoperative length of stay ( compared with standard treatment (moderate certainty).
Prosthetic mesh placement showed no clear difference in stoma‐related infection ( compared with standard treatment (low certainty).
The review found no eligible studies for this question.
Prosthetic mesh placement may leads to lower subgroup analysis: Incidence of parastomal hernia at 12 months compared with standard treatment (low certainty).
Fatty acid showed no clear difference in pressure ulcer incidence: fatty acid vs olive oil compared with other topical intervention or standard care (low certainty).
It is very uncertain whether active topical agent changes stage 3 pressure ulcer incidence: Conotrane vs placebo compared with placebo/control (very low certainty).
It is very uncertain whether active topical agent changes stage 4 pressure ulcer incidence: Conotrane vs placebo compared with placebo/control (very low certainty).
It is very uncertain whether active topical agent changes adverse events: active lotion vs placebo compared with placebo/control (very low certainty).
Silicone dressing may leads to lower pressure ulcer incidence compared with no dressing (low certainty).
It is very uncertain whether silicone dressing changes stage 1 pressure ulcer incidence compared with no dressing (very low certainty).